Lloyd Segal
Chief Executive Officer at REPARE THERAPEUTICS INC.
Net worth: 3 M $ as of 30/11/2022
Profile
Mr. Lloyd M.
Segal is Entrepreneur in Residence at Versant Ventures Canada Ltd.
and Chairman at LMC Diabetes & Endocrinology Ltd.
He is on the Board of Directors at Therapure Biopharma, Inc., The GBC American Growth Fund, Inc., Repare Therapeutics, Inc. and The Growth Fund of America.
Mr. Segal was previously employed as Executive Chairman by Diagnos, Inc., Managing Partner by PCP Management, Inc., Chief Executive Officer by Advanced Bioconcept Ltd., Founding Chief Executive Officer by Caprion Pharmaceuticals, Inc., Management Consultant by McKinsey & Co., Inc. (Canada), Chief Executive Officer by Thallion Pharmaceuticals, Inc., and an Independent Director by Valeant Pharmaceuticals International, Inc.
Mr. Segal received his undergraduate degree from Brandeis University and an MBA from Harvard Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
Pembroke American Growth Fund Inc
inf% | 25/01/2021 | 54,294 ( inf% ) | 2 M $ | 30/11/2022 |
REPARE THERAPEUTICS INC.
0.49% | 01/04/2024 | 207,745 ( 0.49% ) | 978 479 $ | 31/03/2024 |
Lloyd Segal active positions
Companies | Position | Start |
---|---|---|
REPARE THERAPEUTICS INC. | Chief Executive Officer | 01/06/2016 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Director/Board Member | 08/02/2016 |
The Growth Fund of America | Director/Board Member | 15/09/2010 |
Pembroke American Growth Fund, Inc.
Pembroke American Growth Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Pembroke American Growth Fund, Inc. is an open-end investment fund. The company distributes earnings to unit holders as income, dividends or capital gains. It holds interest in pursing long-term growth through capital appreciation by investing in smaller U.S. companies to have above-average growth potential or to be undervalued. The company was founded on October 1, 1988 and is headquartered in Montreal, Canada. | Director/Board Member | 13/03/2006 |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Director/Board Member | - |
Former positions of Lloyd Segal
Companies | Position | End |
---|---|---|
Versant Ventures Canada Ltd. | Private Equity Investor | 01/03/2020 |
Persistence Capital Partners LP | Corporate Officer/Principal | 01/01/2016 |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Director/Board Member | 07/06/2011 |
Advanced Bioconcept Ltd.
Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The private company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998. | Chief Executive Officer | - |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Lloyd Segal
Brandeis University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
DIAGNOS INC. | Technology Services |
BAUSCH HEALTH COMPANIES INC. | Health Technology |
REPARE THERAPEUTICS INC. | Health Technology |
Private companies | 14 |
---|---|
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Caprion Pharmaceuticals, Inc.
Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Caprion Pharmaceuticals, Inc. discovered and developed pharmaceutical products. It offered a proprietary therapeutic pipeline in oncology and infectious diseases. Caprion Pharmaceuticals proteomics discovery technologies used to enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly enhance clinical development productivity and decision making. The company was founded in 1998 and was headquartered in Montreal, Canada. | Health Technology |
The Growth Fund of America | Miscellaneous |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
Advanced Bioconcept Ltd.
Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The private company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998. | Electronic Technology |
Thallion Pharmaceuticals, Inc.
Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada. | Health Technology |
Persistence Capital Partners LP | Finance |
PCP Management, Inc.
PCP Management, Inc. Investment ManagersFinance PCP management Inc (PCP) is a private equity firm founded by Dr. Sheldon Elman & Stuart M Elman in 2008. The firm is headquartered in Montreal, Canada. | Finance |
Pembroke American Growth Fund, Inc.
Pembroke American Growth Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Pembroke American Growth Fund, Inc. is an open-end investment fund. The company distributes earnings to unit holders as income, dividends or capital gains. It holds interest in pursing long-term growth through capital appreciation by investing in smaller U.S. companies to have above-average growth potential or to be undervalued. The company was founded on October 1, 1988 and is headquartered in Montreal, Canada. | Miscellaneous |
McKinsey & Co., Inc. (Canada)
McKinsey & Co., Inc. (Canada) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. (Canada) provides management consulting services for private, public, and social sector institutions. The company is headquartered in Toronto, Canada. | Commercial Services |
Versant Ventures Canada Ltd. | Finance |
MedReleaf Corp.
MedReleaf Corp. Pharmaceuticals: OtherHealth Technology MedReleaf Corp. engages in the production and sale of medical cannabis products. Its cannabis products include dried, oil, oil capsules, and topical creams. The company was founded by Neil J. Closner and Eitan Popper on February 28, 2013 and is headquartered in Markham, Canada. | Health Technology |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Health Services |
LMC Diabetes & Endocrinology Ltd.
LMC Diabetes & Endocrinology Ltd. Hospital/Nursing ManagementHealth Services LMC Diabetes & Endocrinology Ltd. provides complete care in Diabetes, Endocrinology and Metabolism. It provides information on diabetes prevention, type 1 & diabetes, insulin pump therapy, treatment options and helps to overcome obstacles to meet diabetes targets. The firm enables wellness, embracing learning and expanding the therapeutic horizon is integrated into all aspects of centres. The company was founded by Ronnie Aronson in 1997 and is headquartered in Toronto, Canada. | Health Services |
- Stock Market
- Insiders
- Lloyd Segal